Merit Medical Systems will announce Q1 2026 financial results and host an investor call on April 30, 2026.
Quiver AI Summary
Merit Medical Systems, Inc. announced that it will release its financial results for the first quarter of 2026 after the stock market closes on April 30, 2026. The company will hold an investor conference call at 4:30 p.m. Eastern Time on the same day, and participants must pre-register to receive dial-in details. Additional access to a live webcast and a slide deck will be available on the company's website. Founded in 1987, Merit specializes in developing and distributing medical devices for various procedures in healthcare, employing around 7,600 people globally and serving customers through a dedicated sales and clinical support team.
Potential Positives
- Merit Medical Systems is set to announce its financial results for Q1 2026, indicating transparency and commitment to keeping investors informed.
- The investor conference call scheduled for the same day as the financial results showcases the company's engagement with shareholders and facilitates direct communication.
- The detailed logistical information provided for accessing the conference call and webcast reflects a well-organized approach to investor relations.
Potential Negatives
- None
FAQ
When will Merit Medical release Q1 2026 financial results?
Merit Medical will release its financial results on April 30, 2026, after the stock market closes.
What time is the investor conference call?
The investor conference call is scheduled for April 30, 2026, at 4:30 p.m. Eastern Time.
How can I access the conference call?
Please pre-register for the conference call through the provided link to receive dial-in details.
Is there a webcast for the investor conference call?
Yes, a live webcast and slide deck will be accessible on Merit Medical's website.
What products does Merit Medical specialize in?
Merit Medical specializes in proprietary medical devices for interventional, diagnostic, and therapeutic procedures, especially in cardiology and other fields.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$MMSI Insider Trading Activity
$MMSI insiders have traded $MMSI stock on the open market 5 times in the past 6 months. Of those trades, 0 have been purchases and 5 have been sales.
Here’s a breakdown of recent trading of $MMSI stock by insiders over the last 6 months:
- FRED P. LAMPROPOULOS (Executive Chairman) has made 0 purchases and 4 sales selling 60,000 shares for an estimated $5,189,907.
- NEIL W. PETERSON (CHIEF OPERATING OFFICER) sold 5,000 shares for an estimated $450,000
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$MMSI Revenue
$MMSI had revenues of $393.9M in Q4 2025. This is an increase of 10.92% from the same period in the prior year.
You can track MMSI financials on Quiver Quantitative's MMSI stock page.
$MMSI Hedge Fund Activity
We have seen 222 institutional investors add shares of $MMSI stock to their portfolio, and 158 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- MACQUARIE GROUP LTD removed 1,331,579 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $117,365,373
- MAVERICK CAPITAL LTD removed 1,124,048 shares (-69.8%) from their portfolio in Q4 2025, for an estimated $99,073,590
- CITIGROUP INC added 1,035,584 shares (+4390.9%) to their portfolio in Q4 2025, for an estimated $91,276,373
- LOOMIS SAYLES & CO L P removed 447,381 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $39,432,161
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 440,026 shares (-74.3%) from their portfolio in Q4 2025, for an estimated $38,783,891
- POINT72 ASSET MANAGEMENT, L.P. added 436,531 shares (+inf%) to their portfolio in Q4 2025, for an estimated $38,475,842
- FRANKLIN RESOURCES INC removed 423,618 shares (-50.4%) from their portfolio in Q4 2025, for an estimated $37,337,690
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$MMSI Analyst Ratings
Wall Street analysts have issued reports on $MMSI in the last several months. We have seen 5 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Piper Sandler issued a "Overweight" rating on 02/18/2026
- Needham issued a "Buy" rating on 01/09/2026
- Wells Fargo issued a "Overweight" rating on 11/14/2025
- Canaccord Genuity issued a "Buy" rating on 11/14/2025
- Barrington Research issued a "Outperform" rating on 11/14/2025
To track analyst ratings and price targets for $MMSI, check out Quiver Quantitative's $MMSI forecast page.
$MMSI Price Targets
Multiple analysts have issued price targets for $MMSI recently. We have seen 6 analysts offer price targets for $MMSI in the last 6 months, with a median target of $103.5.
Here are some recent targets:
- Mike Matson from Needham set a target price of $101.0 on 04/01/2026
- Larry Biegelsen from Wells Fargo set a target price of $78.0 on 02/26/2026
- Michael Petusky from Barrington Research set a target price of $109.0 on 02/25/2026
- Jason Bednar from Piper Sandler set a target price of $106.0 on 02/18/2026
- Sam Eiber from BTIG set a target price of $107.0 on 02/06/2026
- Jon Young from Canaccord Genuity set a target price of $99.0 on 12/17/2025
Full Release
SOUTH JORDAN, Utah, April 02, 2026 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, announced today that it will release its financial results for the quarter ended March 31, 2026, after the close of the stock market on Thursday, April 30, 2026. Merit plans to hold its investor conference call on the same day (Thursday, April 30, 2026) at 4:30 p.m. Eastern (3:30 p.m. Central, 2:30 p.m. Mountain, and 1:30 p.m. Pacific).
To access the conference call, please pre-register using the following link . Registrants will receive confirmation with dial-in details.
A live webcast and slide deck can be accessed using this link . A link to both register for the conference call and view the webcast will be made available at www.merit.com.
ABOUT MERIT
Founded in 1987, Merit is engaged in the development, manufacture, and distribution of proprietary medical devices used in interventional, diagnostic, and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care, and endoscopy. Merit serves customers worldwide with a domestic and international sales force and clinical support team totaling more than 800 individuals. Merit employs approximately 7,600 people worldwide.
|
Contacts:
|
|
|
PR/Media Inquiries:
Sarah Comstock Merit Medical |
Investor Inquiries:
Mike Piccinino, CFA, IRC ICR Healthcare |
| +1-801-432-2864 | +1-443-213-0509 |
| [email protected] | [email protected] |
